The Economist @TheEconomist
BioNTech reported that sales fell by 40% in the second quarter, year on year, as fewer people are left unjabbed and unboosted. Its share price tumbled by nearly 9% https://t.co/GH1wlL5hgK — PolitiTweet.org
Created
Fri Aug 12 20:11:05 +0000 2022
Likes
31
Retweets
13
Source
SocialFlow
View Raw Data
JSON DataView on Twitter
Likely Available
The Economist @TheEconomist
BioNTech reported that sales fell by 40% in the second quarter, year on year, as fewer people are left unjabbed and unboosted. Its share price tumbled by nearly 9% https://t.co/GH1wlL5hgK — PolitiTweet.org